Hi!
One of the collections we include in the TRIP Database (www.tripdatabase.com) is the American National Guideline Clearinghouse.
We have just been approached with a request to remove one of these guidelines, the Infectious Diseases Society of America practice guidelines for clinical assessment, treatment and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis (http://www.guideline.gov/summary/summary.aspx?doc_id=9537&nbr=5085&ss=6&xl=999).
The reason for this request is that, apparently, the Connecticut DA is examining these guideline due to bias (http://www.canlyme.com/Blum_IDSA_invest_06.html).
I’m wondering if anyone has any views on the case and/or the potential ramifications of this!
Best wishes
jon
Jon Brassey
TRIP Database
www.tripdatabase.com
-----------------------------------------
Email sent from www.ntlworld.com
Virus-checked using McAfee(R) Software
Visit www.ntlworld.com/security for more information
|